A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Public ClinicalTrials.gov record NCT02612558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Open Label, Simon Two-Stage Study to Evaluate the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate whether fostamatinib is safe and effective in the treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA).
Study identification
- NCT ID
- NCT02612558
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2016 (Actual)
- Primary completion
- Dec 2019 (Actual)
- Completion
- Dec 2019 (Actual)
- Last update posted
- Jul 21, 2021
2016 – 2019
United States locations
- U.S. sites
- 31
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Arizona Oncology Associates, PC | Tucson | Arizona | 85711 | — |
| UC San Diego Moores Cancer Center | La Jolla | California | 92093 | — |
| Loma Linda University Cancer Center | Loma Linda | California | 92350 | — |
| LAC/USC Health Center | Los Angeles | California | 90033 | — |
| University of California at San Francisco | San Francisco | California | 94158 | — |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90603 | — |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Mid-Florida Hematology & Oncology Centers, P.A. | Orange City | Florida | 32763 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| Johns Hopkins University School Of Medicine | Baltimore | Maryland | 21205 | — |
| Rcca Md Llc | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| MidMichigan Health Cancer Center | Midland | Michigan | 48640 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Robert Wood Johnson University Hospital | New Brunswick | New Jersey | 08903 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Brody School of Medicine at East Carolina University | Greenville | North Carolina | 27834 | — |
| W.G. "Bill" Hefner VA Medical Center | Salisbury | North Carolina | 28144 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Promedica Flower Hospital | Sylvania | Ohio | 43560 | — |
| M. Francisco Gonzalez, M.D., P.A. | Sumter | South Carolina | 29150 | — |
| Texas Oncology San Antonio Medical Center | San Antonio | Texas | 78240 | — |
| Clear Lake Specialties | Webster | Texas | 77598 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| University of Washington | Seattle | Washington | 98105 | — |
| West Virginia University | Morgantown | West Virginia | 26506 | — |
| Froedtert Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02612558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2021 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02612558 live on ClinicalTrials.gov.